麥迪衞康(02159.HK)2021年淨利464.5萬元 同比減少77.93%
格隆匯3月30日丨麥迪衞康(02159.HK)公吿,截至2021年12月31日止年度的全年業績,公司實現收入7.08億元,同比增長63.86%;股東應占溢利464.5萬元,同比減少77.93%;每股基本盈利2.56分。
2021年集團在互聯網醫院業務取得的成果:隨着新冠疫情、國家集採等新常態化的長期影響及各行各業的數字化轉型升級浪潮,醫療行業各持份者(醫院、醫生、患者、藥械企業等)的需求和行為發生深層的變化,越來越多的診療需求在互聯網醫院發生。集團互聯網醫院平台聚焦於醫生患者的連接及線上優質醫療服務的提供。
截止2021年12月31日,醫生註冊用户數達到30,761人,較2020年增長63.8%,患者用户數達86,729人,較2020年增長235.2%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.